Cargando…
In Silico Design of Dual-Binding Site Anti-Cholinesterase Phytochemical Heterodimers as Treatment Options for Alzheimer’s Disease
The number of patients with neurodegenerative diseases, particularly Alzheimer’s disease (AD), continues to grow yearly. Cholinesterase inhibitors (ChEIs) represent the first-line symptomatic drug treatment for mild-to-moderate AD; however, there is an unmet need to produce ChEIs with improved effic...
Autores principales: | Amat-ur-Rasool, Hafsa, Ahmed, Mehboob, Hasnain, Shahida, Ahmed, Abrar, Carter, Wayne Grant |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8929005/ https://www.ncbi.nlm.nih.gov/pubmed/35723391 http://dx.doi.org/10.3390/cimb44010012 |
Ejemplares similares
-
Anti-Cholinesterase Combination Drug Therapy as a Potential Treatment for Alzheimer’s Disease
por: Amat-ur-Rasool, Hafsa, et al.
Publicado: (2021) -
Designing Second Generation Anti-Alzheimer Compounds as Inhibitors of Human Acetylcholinesterase: Computational Screening of Synthetic Molecules and Dietary Phytochemicals
por: Amat-ur-Rasool, Hafsa, et al.
Publicado: (2015) -
Potential Nutraceutical Properties of Leaves from Several Commonly Cultivated Plants
por: Amat-ur-Rasool, Hafsa, et al.
Publicado: (2020) -
The Psychological Impact of Coronavirus Disease 2019 on Patients Attending a Tertiary Healthcare Facility in Pakistan: A Cross-Sectional Study
por: Ali, Umar Abdul, et al.
Publicado: (2022) -
In Vitro and in Silico Analysis of Phytochemicals From Fallopia dentatoalata as Dual Functional Cholinesterase Inhibitors for the Treatment of Alzheimer’s Disease
por: Wu, Yichuang, et al.
Publicado: (2022)